Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration
Saved in:
Main Authors: | Haruna Matsuda‐Hirose (Author), Naoko Takeo (Author), Masaru Ando (Author), Yumi Kizu (Author), Yutaka Hatano (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
by: Erminia Ridolo, et al.
Published: (2020) -
Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
by: I. S. Krysanov, et al.
Published: (2020) -
Dupilumab in atopic dermatitis patients with chronic hepatitis B
by: Masako Matsutani, et al.
Published: (2022) -
Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis
by: Takahito Chiba, et al.
Published: (2019) -
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
by: Shoko Miyamoto, et al.
Published: (2022)